previous  12345678910...  next  · entire list

New Terrain for Panel on Bailout
2008-11-04, New York Times
http://www.nytimes.com/2008/11/04/business/economy/04bailout.html?partner=rss...

Having been handed vast authority and almost no restrictions in the bailout law that Congress passed ... a committee of five little-known government officials, aided by a bare-bones staff of 40, is picking winners and losers among thousands of banks, savings and loans, insurers and other institutions. It is new and unfamiliar terrain for the officials, who are making monumental decisions — a form of industrial policy, some critics say — that contradict the free market philosophy they usually espouse. Predictably, the process is stirring alarm from Capitol Hill to Wall Street. Among the problems, critics say, is that despite earlier promises of transparency, the process is shrouded in secrecy, its precise goals opaque. Treasury officials have refused to disclose their criteria for deciding which banks ... get money. And officials have yet to say they even have a broader strategy, though banking executives are convinced the government wants to encourage acquisitions. Already, critics from Capitol Hill to Wall Street are lashing out at the program, saying the banks are misusing the capital infusions by hoarding the money rather than lending it. The government, the critics say, is wrongly steering funds to banks to take over weaker rivals. All this comes after Mr. Paulson abruptly shifted the focus of the program to injecting capital rather than buying distressed mortgage-related assets from the banks. This meant that Congress had never debated the details of how the government ought to carry out a recapitalization.

Note: With the intense secrecy and all of the lobbyist and big guns for banking fighting for hundreds of billions of dollars given practically free by the government, do you really think these "five little-known government officials" will be impartial in their decisions? For many revealing, reliable reports on the Wall Street bailout, click here.

So When Will Banks Give Loans?
2008-10-25, New York Times
http://www.nytimes.com/2008/10/25/business/25nocera.html?partner=rssuserland&...

“Chase recently received $25 billion in federal funding. What effect will that have on the business side and will it change our strategic lending policy?” It was Oct. 17, just four days after JPMorgan Chase’s chief executive, Jamie Dimon, agreed to take a $25 billion capital injection courtesy of the United States government, when a JPMorgan employee asked that question [during] an employee-only conference call. The JPMorgan executive who was moderating the employee conference call didn’t hesitate to answer. “What we ... think it will help us do is perhaps be a little bit more active on the acquisition side or opportunistic side for some banks who are still struggling. I think there are going to be some great opportunities for us to grow in this environment, and I think we have an opportunity to use that $25 billion in that way.” Read that answer as many times as you want — you are not going to find a single word in there about making loans to help the American economy. On the contrary: It is starting to appear as if one of Treasury’s key rationales for the recapitalization program — namely, that it will cause banks to start lending again — is a fig leaf, Treasury’s version of the weapons of mass destruction. In fact, Treasury wants banks to acquire each other and is using its power to inject capital to force a new and wrenching round of bank consolidation. Treasury would even funnel some of the bailout money to help banks buy other banks. And, in an almost unnoticed move, it recently put in place a new tax break, worth billions to the banking industry, that has only one purpose: to encourage bank mergers. As a tax expert, Robert Willens, put it: “It couldn’t be clearer if they had taken out an ad.”

Note: Was the real purpose of the "bailout" to strengthen the biggest banks by enabling them to gobble up the smaller ones at the public's expense? No wonder the legislation was rushed through without discussion! For lots more highly revealing reports on the Wall Street bailout, click here.

When Doctors, and Even Santa, Endorsed Tobacco
2008-10-06, New York Times
http://www.nytimes.com/2008/10/07/business/media/07adco.html

People who remember when tobacco advertising was a prominent part of the media landscape ... probably recollect that actors like Barbara Stanwyck and athletes like Mickey Mantle routinely endorsed cigarettes. But how about doctors and other medical professionals, proclaiming the merits of various cigarette brands? Or politicians? Or children? Even Santa Claus? Those images — some flabbergasting, even disturbing — were also used by Madison Avenue to peddle tobacco products. An exhibit ... in New York presents cigarette ads from the 1920s through the early 1950s in an effort to demonstrate what has changed since then — and what may not have. The exhibit is the brainchild of Dr. Robert K. Jackler of the Stanford School of Medicine. “The very best artists and copywriters that money could buy” would work on cigarette accounts, said Dr. Jackler. “This era of over-the-top hucksterism went on for decades,” he added, “and it was all blatantly false.” The genesis of the exhibit was an ad from around 1930 for Lucky Strike cigarettes, which shows a doctor above a headline proclaiming that “20,679 physicians say ‘Luckies are less irritating.’ ” The Luckies doctor was joined in Dr. Jackler’s collection of about 5,000 ads by scores of scientists and medical professionals — doctors, dentists, nurses — making statements that are now known to be patently untrue. Some of the claims being made in the ads, you did not have to be a scientist in a laboratory to dispute ... ads that smoking certain brands “does not cause bad breath” or “can never stain your teeth.”

Note: The Journal of the American Medical Association (JAMA) promoted cigarette ads for 20 years "after careful consideration of the extent to which cigarettes were used by physicians in practice." Will people, even highly respected members of society, bend the truth and even lie when paid enough? This article seems to answer that with a resounding yes. Is that still true today? For excerpts from many highly revealing articles showing it's as true now as ever, click here and here.

Many Firms Didn't Pay Taxes
2008-08-12, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2008/08/11/AR20080811023...

About two-thirds of corporations operating in the United States did not pay taxes annually from 1998 to 2005, according to a [report] from the U.S. Government Accountability Office. In 2005, after collectively making $2.5 trillion in sales, corporations gave a variety of reasons on their tax returns to account for the absence of taxable revenue. The most frequently listed included the cost of producing their goods, salary expenses and interest payments on their debt, the report said. Sen. Byron L. Dorgan (D-N.D.) called the findings "a shocking indictment of the current tax system." "It's shameful that so many corporations make big profits and pay nothing to support our country," he said. "The tax system that allows this wholesale tax avoidance is an embarrassment and unfair to hardworking Americans who pay their fair share of taxes. We need to plug these tax loopholes and put these corporations back on the tax rolls." In 2005, about 28 percent of large corporations paid no taxes. Of the 1.3 million corporations included in the study, 998 were categorized as "large." Dorgan and Sen. Carl M. Levin (D-Mich.) requested the report out of concern that some corporations were using "transfer pricing" to reduce their tax bills. The practice allows multi-national companies to transfer goods and assets between internal divisions so they can record income in a jurisdiction with low tax rates. Levin said: "This report makes clear that too many corporations are using tax trickery to send their profits overseas and avoid paying their fair share in the United States."

Note: For lots more on corporate corruption, click here.

Most companies in US avoid federal income taxes
2008-08-12, Business Week/Associated Press
http://www.businessweek.com/ap/financialnews/D92GQ1982.htm

Unlike the rest of us, most U.S. corporations and foreign companies doing business in the United States pay no federal income tax, according to a new report from Congress. The study by the Government Accountability Office ... said two-thirds of U.S. corporations paid no federal income taxes between 1998 and 2005, and about 68 percent of foreign companies doing business in the U.S. avoided corporate taxes over the same period. Collectively, the companies reported trillions of dollars in sales, according to GAO's estimate. "It's shameful that so many corporations make big profits and pay nothing to support our country," said Sen. Byron Dorgan, D-N.D., who asked for the GAO study. The GAO study did not investigate why corporations weren't paying federal income taxes or corporate taxes and it did not identify any corporations by name. More than 38,000 foreign corporations had no tax liability in 2005 and 1.2 million U.S. companies paid no income tax, the GAO said. Combined, the companies had $2.5 trillion in sales. About 25 percent of the U.S. corporations not paying corporate taxes were considered large corporations, meaning they had at least $250 million in assets or $50 million in receipts. The GAO said it analyzed data from the Internal Revenue Service, examining samples of corporate returns for the years 1998 through 2005. For 2005, for example, it reviewed 110,003 tax returns from among more than 1.2 million corporations doing business in the U.S. "It's time for the big corporations to pay their fair share," Dorgan said.

Note: For many revealing reports on corporate corruption from reliable, verifiable sources, click here.

Global Derivatives Market Expands to $516 Trillion
2007-11-22, Bloomberg News
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=a58EF32GpHeg

The market for derivatives grew at the fastest pace in at least nine years to $516 trillion in the first half of 2007, the Bank for International Settlements said. Credit-default swaps, contracts designed to protect investors against default and used to speculate on credit quality, led the increase, expanding 49 percent to cover a notional $43 trillion of debt in the six months ended June 30, the BIS said in a report published late yesterday. Derivatives of debt, currencies, commodities, stocks and interest rates rose 25 percent from the previous six months, the biggest jump since the Basel, Switzerland-based bank began compiling the data. Investors have been turning to credit derivatives as a way to speculate on a growing risk of defaults amid record U.S. mortgage foreclosures. The money at risk through credit-default swaps increased 145 percent from last year to $721 billion, the report said. The amount at stake in the entire derivatives market is $11.1 trillion, according to the BIS, which was formed in 1930 to monitor financial markets and regulate banks. Derivatives are financial instruments derived from stocks, bonds, loans, currencies and commodities, or linked to specific events like changes in interest rates or the weather. The report is based on contracts traded outside of exchanges in over-the- counter market.

Note: Like most reporting in the major media, this article trivializes the massive size of the derivatives market. $516 trillion is equivalent to $75,000 for every man, woman, and child in the world! Do you think the financial industry is out of control? For lots more powerful, reliable information on major banking manipulations, click here. For a powerful analysis describing just how crazy things have gotten and giving some rays of hope by researcher David Wilcock, click here.

UCSF study questions drug trial results
2007-06-05, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2007/06/05/DRUGS.TMP

Money talks -- and very loudly -- when a drug company is funding a clinical trial involving one of its products. UCSF researchers looked at nearly 200 head-to-head studies of widely prescribed cholesterol-lowering medications, or statins, and found that results were 20 times more likely to favor the drug made by the company that sponsored the trial. "We have to be really, really skeptical of these drug-company-sponsored studies," said Lisa Bero, the study's author and professor of clinical pharmacy and health policy studies. The trials typically involved comparing the effectiveness of a drug to one or two other statins. UCSF researchers also found that a study's conclusions -- not the actual research results but the trial investigators' impressions -- are more than 35 times more likely to favor the test drug when that trial is sponsored by the drug's maker. Bero said drug companies fund up to 90 percent of drug-to-drug clinical trials for certain classes of medication. The researchers found other factors that could affect trial results. For example, pharmaceutical companies could choose not to publish results of studies that fail to favor their drugs, or they could be designed in ways to skew results. The study found the most important weakness of trials was lack of true clinical outcome measures. In the case of statins, some trials focused on less-direct results such as lipid levels but failed to connect the results with key outcomes such as heart attacks or mortality. "None of us really care what our cholesterol level is. We care about having a heart attack," Gibson said. "For the drug to be worthwhile taking, it has to be directly related to prevent a heart attack."

Note: For lots more reliable information about corruption in the pharmaceutical industry, click here.

Doctors Reap Millions for Anemia Drugs
2007-05-09, New York Times
http://www.nytimes.com/2007/05/09/business/09anemia.html?ex=1336363200&en=b68...

Two of the world’s largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. The payments give physicians an incentive to prescribe the medicines at levels that might increase patients’ risks of heart attacks or strokes. At just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. [A] report prepared by F.D.A. staff scientists said no evidence indicated that the medicines either improved quality of life in patients or extended their survival. Several studies suggested that the drugs can shorten patients’ lives when used at high doses. The medicines ... are among the world’s top-selling drugs. They represent the single biggest drug expense for Medicare. Since 1991 ... the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing — and profits. The companies have [failed] to test whether lower doses of the medicines might work better than higher doses. There is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients.

Note: For lots more on major corruption in health care, click here.

Phone cancer report ‘buried’
2007-04-15, The Times (One of the UK's leading newspapers)
http://www.timesonline.co.uk/tol/life_and_style/health/article1655012.ece

T-MOBILE, the mobile phone giant, has been accused of “burying” a scientific report it commissioned that concluded handsets and masts contribute to cancer and genetic damage. The report argued that officially recommended limits on radiation exposure should be cut to 1/1000th of those in force. The suggestion has not been taken up by the company or by regulators. Campaigners claimed T-Mobile’s handling of the report was part of a wider pattern of behaviour by the industry in its efforts to keep discussion of the health risks off the agenda. The Ecolog Institute, which has been researching mobile phone technology since 1992, was paid by T-Mobile to evaluate evidence on its potential dangers. But Dr Peter Neitzke, one of the authors of the report, has accused T-Mobile ... of diluting the findings by commissioning other studies from which it knew “no critical results or recommendations were to be expected”. Ecolog’s report, which analysed dozens of peer-reviewed studies, stated: “Given the results of the present epidemiological studies, it can be concluded that electromagnetic fields with frequencies in the mobile telecommunications range do play a role in the development of cancer. This is particularly notable for tumours of the central nervous system.”

Note: For many highly important articles from reliable sources on major health issues, click here.

Under The Influence
2007-04-02, CBS News
http://www.cbsnews.com/stories/2007/03/29/60minutes/main2625305.shtml

If you have ever wondered why the cost of prescription drugs in the United States are the highest in the world or why it's illegal to import cheaper drugs from Canada or Mexico, you need look no further than the pharmaceutical lobby and its influence in Washington, D.C. Congressmen are outnumbered two to one by lobbyists for an industry that spends roughly a $100 million a year in campaign contributions and lobbying expenses to protect its profits. One reason [drug company] profits have exceeded Wall Street expectations is the Medicare prescription drug bill ... passed three-and-a-half years ago. The unorthodox roll call on one of the most expensive bills ever placed before the House of Representatives began in the middle of the night. The only witnesses were congressional staffers, hundreds of lobbyists, and U.S. Representatives like Dan Burton, R-Ind., and Walter Jones, R-N.C. "The pharmaceutical lobbyists wrote the bill," says Jones. Why did the vote finally take place at 3 a.m.? "They didn't want on national television in primetime," according to Burton. "I've been in politics for 22 years," says Jones, "and it was the ugliest night I have ever seen." Jones says the arm-twisting was horrible. It certainly wasn't ugly for the drug lobby which ... has been a source of lucrative employment opportunities for congressmen when they leave office. In all, at least 15 congressional staffers, congressmen and federal officials left to go to work for the pharmaceutical industry, whose profits were increased by several billion dollars. "They have unlimited resources," Burton says. "And when they push real hard to get something accomplished in the Congress of the United States, they can get it done."

Note: This article also states that the Medicare prescription bill "was the largest entitlement program in more than 40 years, and the debate broke down along party lines." Usually Republicans are against entitlement programs while Democrats support them. Why was it the opposite in this case? Could it be that big industry made huge profits from the passage of this bill? For lots more, click here.

It's still about oil in Iraq
2006-12-08, Los Angeles Times
http://www.latimes.com/news/opinion/la-oe-juhasz8dec08,0,4717508.story

While the Bush administration, the media and nearly all the Democrats still refuse to explain the war in Iraq in terms of oil, the ever-pragmatic members of the Iraq Study Group share no such reticence. Page 1, Chapter 1 ... lays out Iraq's importance: "It has the world's second-largest known oil reserves." The report makes visible to everyone the elephant in the room: that we are fighting, killing and dying in a war for oil. Recommendation No. 63 ... calls on the U.S. to "assist Iraqi leaders to reorganize the national oil industry as a commercial enterprise." This is an echo of calls made [by] the U.S. State Department's Oil and Energy Working Group, meeting between December 2002 and April 2003. Iraq "should be opened to international oil companies as quickly as possible after the war." Its preferred method of privatization was a form of oil contract called a production-sharing agreement. These agreements are ... rejected by all the top oil producers in the Middle East because they grant greater control and more profits to the companies than the governments. For any degree of oil privatization to take place ... Iraq has to amend its constitution. Recommendation No. 26 of the Iraq Study Group calls for a review of the constitution to be "pursued on an urgent basis." Petroleum Economist magazine later reported that U.S. oil companies considered passage of the new oil law more important than increased security. Further, the Iraq Study Group would commit U.S. troops to Iraq for several more years to ... provide security for Iraq's oil infrastructure. We can thank the Iraq Study Group for making its case publicly. It is now our turn to decide if we wish to spill more blood for oil.

Note: For more on corporate complicity in fomenting war exposed by a top U.S. general, click here.

Class Struggle
2006-11-15, Wall Street Journal
http://www.opinionjournal.com/editorial/feature.html?id=110009246

The most important--and unfortunately the least debated--issue in politics today is our society's steady drift toward a class-based system, the likes of which we have not seen since the 19th century. America's top tier has grown infinitely richer and more removed over the past 25 years. Few among them send their children to public schools; fewer still send their loved ones to fight our wars. They own most of our stocks, making the stock market an unreliable indicator of the economic health of working people. The top 1% now takes in an astounding 16% of national income, up from 8% in 1980. The tax codes protect them, just as they protect corporate America, through a vast system of loopholes. Incestuous corporate boards regularly approve compensation packages for chief executives and others that are out of logic's range. As this newspaper has reported, the average CEO of a sizeable corporation makes more than $10 million a year, while the minimum wage for workers amounts to about $10,000 a year, and has not been raised in nearly a decade. When I graduated from college in the 1960s, the average CEO made 20 times what the average worker made. Today, that CEO makes 400 times as much. Trickle-down economics didn't happen. Wages and salaries are at all-time lows as a percentage of the national wealth. This ever-widening divide is too often ignored or downplayed by its beneficiaries. A sense of entitlement has set in among elites, bordering on hubris.

Note: For some reason the Wall Street Journal has removed this article. You can read it on the website of the article's author at this link.

Donald Rumsfeld makes $5m killing on bird flu drug
2006-03-12, Independent (one of the UK's leading newspapers)
http://news.independent.co.uk/world/americas/article350787.ece

The US Defence Secretary has made more than $5m (£2.9m) in capital gains from selling shares in the biotechnology firm that discovered and developed Tamiflu, the drug being bought in massive amounts by Governments to treat a possible human pandemic of the disease. More than 60 countries have so far ordered large stocks of the antiviral medication - the only oral medicine believed to be effective against the deadly H5N1 strain of the disease - to try to protect their people. The United Nations estimates that a pandemic could kill 150 million people worldwide. The drug was developed by a Californian biotech company, Gilead Sciences. Mr Rumsfeld was on the board of Gilead from 1988 to 2001, and was its chairman from 1997. He then left to join the Bush administration, but retained a huge shareholding. The 2005 report showed that, in all, he owned shares worth up to $95.9m, from which he got an income of up to $13m. The firm made a loss in 2003, the year before concern about bird flu started. Then revenues from Tamiflu almost quadrupled, to $44.6m, helping put the company well into the black. Sales almost quadrupled again, to $161.6m last year.

Note: If the above link fails, click here. With both the avian flu and swine flu, top drug companies raked in billions of dollars from sales of medications and vaccines, most of which went unused and have now expired. For many more strange coincidences and facts around the avian and swine flu scares, take a look at our summary of eye-opening news articles available here.

Out of Control: AIDS and the corruption of medical science
2006-03-01, Harper's Magazine
http://harpers.org/archive/2006/03/0080961

HIV tests detect footprints, never the animal itself. These footprints, antibodies ... were limited to two in 1984 ... but over the years expanded to include many proteins previously not associated with HIV. A majority of HIV-positive tests, when retested, come back indeterminate or negative. In many cases, different results emerge from the same blood tested in different labs. There are currently at least eleven different criteria for how many and what proteins at which band density signal “positive.” The most stringent criteria (four bands) are upheld in Australia and France; the least stringent (two bands), in Africa, where an HIV test is not even required as part of an AIDS diagnosis. Africa ... has become ground zero of the AIDS epidemic. The clinical definition of AIDS in Africa, however, is stunningly broad and generic, and was seemingly designed to be little other than a signal for funding. The “Bangui definition” of AIDS ... requires neither a positive HIV test nor a low T-cell count, as in the West, but only the presence of chronic diarrhea, fever, significant weight loss, and asthenia. These happen to be the symptoms of chronic malnutrition, malaria, parasitic infections, and other common African illnesses. The statistical picture of AIDS in Africa, consequently, is a communal projection based on very rough estimates ... extrapolated across the continent using computer models and highly questionable assumptions. More than 2,300 people, mostly scientists and doctors, including Nobelists in chemistry and medicine, have signed the petition of the Group for the Scientific Reappraisal of the HIV-AIDS Hypothesis, which calls for a more independent and skeptical approach to the question of AIDS causality.

Note: If you want to be educated about the details of how rampant corruption has become in the medical research industry, read this well researched article. For a concise description of unbridled corruption in the health care industry by one of the most respected doctors in the world, click here.

Kids Build Soybean-Fueled Car
2006-02-17, CBS News
http://www.cbsnews.com/stories/2006/02/17/eveningnews/main1329941.shtml

The star at last week's Philadelphia Auto Show wasn't a sports car or an economy car. It was a sports-economy car — one that combines performance and practicality under one hood. But as CBS News correspondent Steve Hartman reports in this week's Assignment America, the car that buyers have been waiting decades [for] comes from an unexpected source and runs on soybean bio-diesel fuel to boot. A car that can go from zero to 60 in four seconds and get more than 50 miles to the gallon would be enough to pique any driver's interest. So who do we have to thank for it. Ford? GM? Toyota? No — just Victor, David, Cheeseborough, Bruce, and Kosi, five kids from the auto shop program at West Philadelphia High School. The five kids ... built the soybean-fueled car as an after-school project. It took them more than a year — rummaging for parts, configuring wires and learning as they went. As teacher Simon Hauger notes, these kids weren't exactly the cream of the academic crop. "If you give kids that have been stereotyped as not being able to do anything an opportunity to do something great, they'll step up," he says. Stepping up is something the big automakers have yet to do. They're still in the early stages of marketing hybrid cars while playing catch-up to the Bad News Bears of auto shop. "We made this work," says Hauger. "We're not geniuses. So why aren't they doing it?" Kosi thinks he knows why. The answer, he says, is the big oil companies.

Note: So why isn't this remarkable engine design breakthrough making front page headlines in all major media? Why aren't the many other major energy breakthroughs that have been reported given the headlines they deserve? Could it be that those who are reaping huge profits from oil sales have much more political and media influence than you might imagine? For lots more reliable information on this, click here.

Doctor says bird flu drug is ‘useless’
2005-12-04, London Times
http://www.timesonline.co.uk/article/0,,2091-1903144,00.html

A Vietnamese doctor who has treated dozens of victims of avian flu claims the drug being stockpiled around the world to combat a pandemic is 'useless' against the virus. Dr Nguyen Tuong Van runs the intensive care unit at the Centre for Tropical Diseases in Hanoi and has treated 41 victims of H5N1. Van followed World Health Organisation (WHO) guidelines and gave her patients Tamiflu, but concluded it had no effect. 'We place no importance on using this drug on our patients,' she said. 'Tamiflu is really only meant for treating ordinary type A flu. It was not designed to combat H5N1 . . . (Tamiflu) is useless.' Roche, the company that makes Tamiflu, has sold stockpiles of the drug to 40 countries and insists there is clear evidence it will protect against a future flu virus. However, it stresses the drug must be given within 48 hours to be effective. The WHO admitted Tamiflu had not been widely successful in humans. 'However, we believe in many Asian countries it hasn't been used until late in the illness,' a spokesman said.

Note: Yet hundreds of millions of dollars are being spent to stockpile this drug. It's quite interesting that the former chairman of the board of directors of the company that made Tamiflu is current Secretary of Defense Donald Rumsfeld. Mr. Rumsfeld has had over $5 million in stock gains from the sales of this drug. To read about this and lots more: http://www.WantToKnow.info/avianflu

Refiners Maintain a Firm but Legal Grip on Supplies
2005-06-18, Los Angeles Times
http://www.latimes.com/business/la-fi-calgas18jun18,0,7589520.story

California refiners are simply cashing in on a system that allows a handful of players to keep prices high by carefully controlling supplies. The result is a kind of miracle market in which profits abound, outsiders can't compete and a dwindling cadre of gas station operators has little choice but go along. Refiners "not only control how much supply is in the marketplace, they control who gets it and at what price," said Dennis DeCota, executive director of the California Service Station and Automotive Repair Assn. The recent history of California's fuel industry is a textbook case of how a once-competitive business can become skewed to the advantage of a few, all with the federal government's blessing. Refiners acknowledge their California businesses have become the most profitable in the nation. The rest of the country isn't far behind. Characteristics once unique to California — specialty fuels, a refinery shortage, the growing dominance of a few companies — have begun to plague other gasoline markets.

Deadly Immunity - by Robert F. Kennedy, Jr.
2005-06-16, Common Dreams/Boston Globe
http://www.commondreams.org/views05/0616-31.htm

In June 2000, a group of top government scientists and health officials gathered for a meeting at the isolated Simpsonwood conference center...to ensure complete secrecy. The federal officials and industry representatives had assembled to discuss a disturbing new study that raised alarming questions about the safety of a host of common childhood vaccines administered to infants and young children. A mercury-based preservative in the vaccines -- thimerosal -- appeared to be responsible for a dramatic increase in autism. But instead of taking immediate steps to alert the public and rid the vaccine supply of thimerosal, the officials and executives at Simpsonwood spent most of the next two days discussing how to cover up the damaging data. According to transcripts obtained under the Freedom of Information Act, many at the meeting were concerned about how the damaging revelations about thimerosal would affect the vaccine industry's bottom line. The CDC paid the Institute of Medicine to conduct a new study to whitewash the risks of thimerosal, ordering researchers to "rule out" the chemical's link to autism. Senate Majority Leader Bill Frist, who has received $873,000 in contributions from the pharmaceutical industry, has been working to immunize vaccine makers from liability in 4,200 lawsuits that have been filed by the parents of injured children. More than 500,000 kids currently suffer from autism. The disease was unknown until 1943, when it was identified and diagnosed among 11 children born in the months after thimerosal was first added to baby vaccines in 1931. Internal documents reveal that Eli Lilly, which first developed thimerosal, knew from the start that its product could cause damage -- and even death -- in both animals and humans.

Note: A good, though somewhat watered down version of the above article was published in the Boston Globe on July 1, 2005. To see this article on the Globe website, click here.

Big Pharma snared by net
2004-09-26, The Observer (One of the U.K.'s leading newspapers)
http://observer.guardian.co.uk/business/story/0,,1312765,00.html

No one foresaw ... the shocking extent to which the internet would change the terms of trade between corporations and society. One of the world's largest drug companies [was] the first victim. Britain's GlaxoSmithKline, the world's second-largest pharma, denied any wrongdoing, but agreed to pay $2.5m ... for concealing evidence of its antidepressant Seroxat's potential for harming children, while doing them no measurable good. Infinitely more frightening ... this pharma had the backing of institutions that we, the public, rely on to protect us from poisoning by prescription. The Royal College of Psychiatrists had insisted only a year earlier that 'there is no evidence that antidepressant drugs can cause dependence syndromes'. It was really the internet that allowed public health activists to do an end run around GSK's and the medical authorities' denials of the drug's risks. An explosion of websites dedicated to vivid accounts of antidepressant reactions told these campaigners about hundreds of thousands affected by a problem that officially did not exist. Health activists in Britain and America have uncovered the core of pharma might. In both countries, clinical drug tests are paid for by the pharmas, who tweak the trials' design for the best possible results. Until recently, only the most favourable findings got published in the 20,000-odd biomedical journals, many of them dependent on pharmas for funding. The drugs are approved for marketing by regulators, whose salaries are mostly financed by the subjects of their evaluations. The medicines are then prescribed by doctors routinely courted with pharma gifts ... meant to persuade them to change their prescribing habits.

Note: For a two-page summary with lots more reliable information on major health cover-ups by a doctor who was editor-in-chief of one of the most pretigious medical journals in the world, click here.

Bilderberg: The ultimate conspiracy theory
2004-06-03, BBC News
http://news.bbc.co.uk/1/hi/magazine/3773019.stm

The Bilderberg group, an elite coterie of Western thinkers and power-brokers, has been accused of fixing the fate of the world behind closed doors. As the organisation marks its 50th anniversary, rumours are more rife than ever. On Thursday the Bilderberg group marks its 50th anniversary with the start of its yearly meeting. For four days some of the West's chief political movers, business leaders, bankers, industrialists and strategic thinkers will hunker down in a five-star hotel in northern Italy to talk about global issues. What sets Bilderberg apart from other high-powered get-togethers, such as the annual World Economic Forum (WEF), is its mystique. Not a word of what is said at Bilderberg meetings can be breathed outside. No reporters are invited in and while confidential minutes of meetings are taken, names are not noted. A former journalist, Mr Gosling runs a campaign against the group from his home in Bristol, UK." One of the first places I heard about the determination of US forces to attack Iraq was from leaks that came out of the 2002 Bilderberg meeting," says Mr Gosling.

previous

12345678910...

next

· entire list